# Zbigniew K. Wszołek

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/zbigniew-k-wszo-ek/

## Facts

| Field | Value |
| --- | --- |
| Citations | 58,554 |
| Field | Parkinson's Disease Mechanisms and Treatments |
| h-index | 113 |
| i10-index | 532 |
| Last Known Institution | Jacksonville College |
| OpenAlex ID | https://openalex.org/A5022481370 |
| ORCID iD | https://orcid.org/0000-0001-5487-1053 |
| Works | 974 |

## Researcher papers

- [Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS](https://scholariq.org/papers/expanded-ggggcc-hexanucleotide-repeat-in-noncoding-region-of-c9orf72-causes/)
- [Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology](https://scholariq.org/papers/mutations-in-lrrk2-cause-autosomal-dominant-parkinsonism-with-pleomorphic/)
- [Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease](https://scholariq.org/papers/common-variants-at-abca7-ms4a6a-ms4a4e-epha1-cd33-and-cd2ap-are-associated-with/)
- [Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study](https://scholariq.org/papers/phenotype-genotype-and-worldwide-genetic-penetrance-of-lrrk2-associated/)
- [Clinical Correlations With Lewy Body Pathology in<i>LRRK2</i>-Related Parkinson Disease](https://scholariq.org/papers/clinical-correlations-with-lewy-body-pathology-in-i-lrrk2-i-related-parkinson/)
- [Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder](https://scholariq.org/papers/clinicopathologic-correlations-in-172-cases-of-rapid-eye-movement-sleep-behavior/)
- [Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study](https://scholariq.org/papers/association-of-lrrk2-exonic-variants-with-susceptibility-to-parkinson-s-disease/)
- [Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study](https://scholariq.org/papers/age-at-symptom-onset-and-death-and-disease-duration-in-genetic-frontotemporal/)
- [Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis](https://scholariq.org/papers/identification-of-novel-risk-loci-for-restless-legs-syndrome-in-genome-wide/)
- [Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options](https://scholariq.org/papers/tauopathies-with-parkinsonism-clinical-spectrum-neuropathologic-basis-biological/)
- [Utility of the global CDR<sup>®</sup> plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium](https://scholariq.org/papers/utility-of-the-global-cdr-sup-sup-plus-nacc-ftld-rating-and-development-of/)
- [Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease](https://scholariq.org/papers/age-and-disease-dependent-increase-of-the-mitophagy-marker-phospho-ubiquitin-in/)

## Researcher topics

- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Neurological diseases and metabolism](https://scholariq.org/topics/neurological-diseases-and-metabolism/)
- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)

## Researcher university

- [Jacksonville College](https://scholariq.org/institutions/jacksonville-college/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
